SCHEMBL3360271

SCHEMBL3360271

CC(CO)(CO)C(=CCO)C(=O)O

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.31
TSHR P16473 1/20 0.31
CYP2C19 P33261 1/20 0.31
HIF1A Q16665 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7174689 0.81
SCHEMBL1848365 0.76
SCHEMBL3366377 0.72 EP300 (0.31)
SCHEMBL15809892 0.70
SCHEMBL9287051 0.68 TSHR (0.32) TSHR
SCHEMBL181160 0.66 TSHR (0.55) CYP2D6TSHRCYP2C19HIF1A
Oxalic Acid SCHEMBL28184574 0.66 TSHR (0.37) CYP2D6TSHRCYP2C19HIF1A
SCHEMBL26766 0.66
Allyl Alcohol SCHEMBL27761304 0.65 TSHR (0.43) CYP2D6TSHRCYP2C19HIF1A
SCHEMBL337233 0.64 TSHR (0.52) CYP2D6TSHRCYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4582022-A1 SENSORS FOR CONTINUOUS ANALYTE MONITORING DexCom, Inc. (US) 2025-07-09 EP disclosed
EP-3570749-B1 SENSORS FOR CONTINUOUS ANALYTE MONITORING DEXCOM INC (US) 2025-06-04 EP disclosed
US-20240407682-A1 SENSORS FOR CONTINUOUS ANALYTE MONITORING DEXCOM, INC. (US) 2024-12-12 US disclosed
US-12089933-B2 Sensors for continuous analyte monitoring DEXCOM, INC. (US) 2024-09-17 US disclosed
US-20220409138-A1 SENSORS FOR CONTINUOUS ANALYTE MONITORING DEXCOM, INC. (US) 2022-12-29 US disclosed
US-11457870-B2 Sensors for continuous analyte monitoring DEXCOM, INC. (US) 2022-10-04 US disclosed
EP-2185701-A2 COMPOSITIONS AND METHODS FOR MODIFYING PROPERTIES OF BIOLOGICALLY ACTIVE POLYPEPTIDES Amunix, Inc. (US) 2010-05-19 EP disclosed
WO-2010006194-A2 NON-COVALENT MODIFICATION OF MICROPARTICLES AND PROCESS OF PREPARING SAME BAXTER INTERNATIONAL INC. (US) 2010-01-14 WO disclosed
WO-2009023270-A2 COMPOSITIONS AND METHODS FOR MODIFYING PROPERTIES OF BIOLOGICALLY ACTIVE POLYPEPTIDES AMUNIX, INC. (US) 2009-02-19 WO disclosed
WO-2004058308-A1 AN EFFICIENT NON-VIRAL GENE/DRUG DELIVERY SYSTEM BOARD OF REGENTS THE UNIVERSITY OF TEXAS SYSTEM (US) 2004-07-15 WO disclosed
WO-1996020012-A2 METHODS FOR PREPARING AND PURIFYING MACROMOLECULAR CONJUGATES MIDDLESEX SCIENCES, INC. (US) 1996-07-04 WO disclosed